Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

CenTrak Expands IoT Location and Sensing Services to Awarepoint Customers

KLAS Category Leader for RTLS promotes further IoT technology adoption to streamline healthcare delivery and improve the patient experience

CenTrak announced today the transfer of select assets of Awarepoint to its subsidiary Clinical Patents LLC (CPLLC). The transfer of assets will further expand CenTrak’s market-leading IoT Location and Sensing services with the addition of Bluetooth Low Energy (BLE) sensor technology.

The transfer includes over twenty patents, many which are focused on mobile device locating and enhancing the accuracy and performance of traditional BLE systems. For existing Awarepoint customers, resources are in place to offer service and support. Awarepoint engineering and technical support personnel have been hired by CPLLC to ensure continuity of support. Awarepoint customers can speak with dedicated resources regarding conversion and upgrade options and report technical support issues. Please visit www.centrak.com/awarepoint or call 215-860-2928 x336 for details.

Awarepoint technology has been installed in hundreds of prominent hospitals and clinics throughout North America, leveraging hundreds of thousands of IoT sensors and tags. CenTrak now has access to key technology features, including mobile device locating to supplement CenTrak’sConnect™ platform, where it can be synthesized with the other technologies CenTrak already supports, including: Wi-Fi, Second Generation Infrared (Gen2IR™), UHF Active RFID, Low Frequency, Passive RFID, BLE and Advanced Ultrasound (IRUS™). The combination of these technologies will further expand the breadth of use cases which can be addressed using healthcare’s leading provider of Enterprise-class Location and Sensing Services.

“We are excited and hopeful that this transaction will help to further standardize quality Location and Sensory services in healthcare,” said CenTrak’s President and CEO, Ari Naim. “This IoT technology is improving workflow efficiencies and generating cost reductions, while enhancing patient care. Our scalable platform and vast ecosystem of Solution Providers and Systems Integrators enable customers to easily deploy the technology throughout their entire facility for maximum utility benefit.”